BiotechTube

modafinil

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Methamphetamine Addiction

Conditions

Methamphetamine Addiction

Trial Timeline

Jan 1, 2008 → Jun 1, 2011

NCT ID
NCT00538655

About modafinil

modafinil is a phase 2 stage product being developed by Pacific Biosciences for Methamphetamine Addiction. The current trial status is completed. This product is registered under clinical trial identifier NCT00538655. Target conditions include Methamphetamine Addiction.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (3)

NCT IDPhaseStatus
NCT01354470Phase 2Completed
NCT00630097Phase 2UNKNOWN
NCT00538655Phase 2Completed

Competing Products

6 competing products in Methamphetamine Addiction

See all competitors
ProductCompanyStageHype Score
CPP-109 vigabatrin + Matching PlaceboCatalyst PharmaceuticalsPhase 2
47
A single oral 5 mg of duterium labeled methamphetaminePacific BiosciencesApproved
77
Dextroamphetamine + PlaceboPacific BiosciencesPhase 2
44
NaltrexonePacific BiosciencesPhase 2
44
ModafinilPacific BiosciencesPhase 2
44
Ibudilast 20mg + Ibudilast 50mg + Placebo oral tabletMediciNovaPhase 1
25

Other Products from Pacific Biosciences

pantoprazole + bismuth + metronidazole + tetracyclineApproved
77
EmtricitabineApproved
77
A single oral 5 mg of duterium labeled methamphetamineApproved
77
RamiprilApproved
77
Emtricitabine plus adefovir dipivoxilApproved
77